Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR) in Subjects With Heterogeneous Emphysema

NCT01101958 is registered in ClinicalTrials.gov with Pulmonx Corporation as lead sponsor.

NCT NCT01101958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01101958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Use of Chartis System to Optimize Subject Selection for Endobronchial Lung Volume Reduction (ELVR) in Subjects With Heterogeneous Emphysema
Lead sponsor
Pulmonx Corporation
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
March 31, 2013
Enrollment
96 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

emphysema